Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 151 entries
View as:

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT02227693 Org: User:
Start: 07/31/14 End: 04/01/15 Due: 04/01/16

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01390714 Org: User:
Start: 07/31/11 End: 10/31/11 Due: 10/31/12

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02162264 Org: User:
Start: 06/01/13 End: 07/22/16 Due: 07/22/17

Study of E3810 for Healthy Japanese Male (Under Fasting Condition)

Phase: N/A Priority: Normal
NCT ID: NCT01085695 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

Phase: N/A Priority: Normal
NCT ID: NCT01843556 Org: User:
Start: 12/31/12 End: 06/30/13 Due: 06/30/14

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Phase: N/A Priority: Normal
NCT ID: NCT00849212 Org: User:
Start: 04/30/09 End: 11/30/09 Due: 11/30/10

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

Phase: N/A Priority: Normal
NCT ID: NCT00125736 Org: User:
Start: 08/01/05 End: 04/19/07 Due: 04/19/08

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03399734 Org: User:
Start: 12/18/17 End: 03/09/18 Due: 03/09/19

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants

Phase: N/A Priority: Normal
NCT ID: NCT05278663 Org: User:
Start: 04/14/22 End: 09/04/23 Due: 09/04/24

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

Phase: N/A Priority: Normal
NCT ID: NCT01715493 Org: User:
Start: 10/31/12 End: 01/31/14 Due: 01/31/15

Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03055962 Org: User:
Start: 02/14/17 End: 04/11/17 Due: 04/11/18

Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02268838 Org: User:
Start: 10/31/14 End: 11/30/15 Due: 11/30/16

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Phase: N/A Priority: Normal
NCT ID: NCT00903786 Org: User:
Start: 06/17/09 End: 10/31/16 Due: 10/31/17

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Phase: N/A Priority: Normal
NCT ID: NCT01264822 Org: User:
Start: 01/13/11 End: 11/17/16 Due: 11/17/17

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02660983 Org: User:
Start: 08/05/13 End: 12/21/18 Due: 12/21/19

Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)

Phase: N/A Priority: Normal
NCT ID: NCT01463891 Org: User:
Start: 07/19/11 End: 11/27/13 Due: 11/27/14

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Phase: N/A Priority: Normal
NCT ID: NCT03833700 Org: User:
Start: 03/05/19 End: 01/31/26 Due: 01/31/27

A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)

Phase: N/A Priority: Normal
NCT ID: NCT01085708 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

A Study of Lemborexant in Chinese Participants With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04549168 Org: User:
Start: 11/06/20 End: 03/17/23 Due: 03/17/24

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00770913 Org: User:
Start: 10/31/08 End: 03/31/10 Due: 03/31/11

A Study of E7130 in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03444701 Org: User:
Start: 02/05/18 End: 12/27/24 Due: 12/27/25

A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics

Phase: N/A Priority: Normal
NCT ID: NCT02960490 Org: User:
Start: 11/26/16 End: 11/25/19 Due: 11/25/20

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase: N/A Priority: Normal
NCT ID: NCT00444613 Org: User:
Start: 04/30/07 End: 07/31/14 Due: 07/31/15

A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02146261 Org: User:
Start: 09/30/13 End: 04/30/14 Due: 04/30/15

A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103)

Phase: N/A Priority: Normal
NCT ID: NCT01773434 Org: User:
Start: 12/31/12 End: 10/31/16 Due: 10/31/17